参考文献/References:
[1] 茆勇军,李海泓,李剑峰,等.蛋白酪氨酸激酶信号转导途径与抗肿瘤药物 [J].药学学报,2008,43(4):323-334.
[2] Arora A,Scholar E M.Role of tyrosine kinase inhibitors in cancertherapy [J].J Pharmacol Exp Ther,2005,315(3):971-979.
[3] Sarker D,Molife R,Evans T R J,et al.A phase I pharmaco-kinetic and pharmacodynamic study of TKI258,an ora,l multitargeted receptor tyrosine kinase inhibitor in patients with advanced solid tumors [J].Clin Cancer Res,2008,14(7):2075-2081.
[4] John B Hynes,Alpana Pathak,Constantina H Panes,et al.Direct synthesis of 2,4-diaminoquinazolines from 2-fluorobenzonitriles [J].Journal of Heterocyclic Chemistry,1988,25(4):1173-1177.
[5] Dieter H Klaubert,John H Sellstedt,Charles J Guinosso,et al.N-(Aminopheny1)oxamic acids and esters as potent,orally active antiallergy agents [J].Journal of Medicinal Chemistry,1981,24(6):742-748.
[6] Calvin G,Harwood E,Ryckman D,et al.Methods for synthesizing heterocyclic compounds:WO,2006125130 [P].2006-11-23.
[7] 喻理德,崔汉峰,袁金斌,等.异丁基硼酸的超声辐射合成 [J].江西师范大学学报:自然科学版,2012,36(14):415-416.
[8] William R Antonios-McCrea,Kelly A Frazier,Elisa M Jazan,et al.LHMDS mediated tandem acylation-cyclization of 2-aminobenzenecarbonitriles with 2-benzymidazol-2-yl acetates:a short and efficient route to the synthesis of 4-amino-3-benzimidazol-2-ylhydroquinolin-2-ones [J].Tetrahedron Letters,2006,47:657-660.
[9] Paul A Renhowe,Sabina Pecchi,Cynthia M Shafer,et al.Design,structure-activity relationships and in vivo characterization 4-amino-3-benzimidazol-2-ylhydroquinolin-2-ones:A novel class of receptor tyrosine kinase inhibitors [J].Journal of Medicinal Chemistry,2009,52(2):278-292.